Showing results 41 to 60 of 119
< previous
next >
Issue Date | Title | Author(s) |
2022-01-01 | Optimization Studies on Imatinib Mesylate Loaded Nanoliposomes Using Box-Behnken Design | Dahiya, M; Awasthi, R; Gupta, G; Singh, SK; Gulati, M; Jha, NK; Jha, SK; Sharma, A; Prasher, P; Anand, K; Chellappan, DK; Dua, K; Dureja, H |
2022-01-01 | Advanced drug delivery systems for targeting obesity | Gulati, N; Dua, K; Dureja, H |
2022 | Chemical Moieties as Advanced Therapeutics for Targeting Respiratory Disorders | Prasher, P; Sharma, M; Kapoor, DN; Negi, P; Gupta, G; Zacconi, FC; Tambuwala, MM; Mehta, M; Satija, S; Dureja, H; Chellappan, DK; Dua, K |
2022 | Vesicular Drug Delivery Systems in Respiratory Diseases | Satija, S; Dhanjal, DS; Sharma, P; Hussain, MS; Chan, Y; Ng, SW; Prasher, P; Dureja, H; Chopra, C; Singh, R; Gupta, G; Chellappan, DK; Dua, K; Mehta, M |
2021-12-16 | Overcoming hydrolytic degradation challenges in topical delivery: Non-aqueous nano-emulsions. | Kadukkattil Ramanunny, A; Singh, SK; Wadhwa, S; Gulati, M; Kapoor, B; Khursheed, R; Kuppusamy, G; Dua, K; Dureja, H; Chellappan, DK; Jha, NK; Gupta, PK; Vishwas, S |
2021-12 | Microfluidic chips: recent advances, critical strategies in design, applications and future perspectives | Pattanayak, P; Singh, SK; Gulati, M; Vishwas, S; Kapoor, B; Chellappan, DK; Anand, K; Gupta, G; Jha, NK; Gupta, PK; Prasher, P; Dua, K; Dureja, H; Kumar, D; Kumar, V |
2021-10-15 | Protein and peptide delivery to lungs by using advanced targeted drug delivery. | Chellappan, DK; Prasher, P; Saravanan, V; Vern Yee, VS; Wen Chi, WC; Wong, JW; Wong, JK; Wong, JT; Wan, W; Chellian, J; Molugulu, N; Prabu, SL; Ibrahim, R; Darmarajan, T; Candasamy, M; Singh, PK; Mishra, V; Khurana, N; Shastri, MD; Satija, S; Zacconi, FC; Chakraborty, A; Mehta, M; Gupta, PK; Dureja, H; Gulati, M; Singh, SK; Gupta, G; Jha, NK; George Oliver, BG; Dua, K |
2021-09 | Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospects | Gulati, N; Chellappan, DK; MacLoughlin, R; Dua, K; Dureja, H |
2021-07-01 | Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19 | Jeyaraman, M; Muthu, S; Bapat, A; Jain, R; ES, S; Gulati, A; Channaiah Anudeep, T; Dilip, SJ; Jha, NK; Kumar, D; Kesari, KK; Ojha, S; Dholpuria, S; Gupta, G; Dureja, H; Chellappan, DK; Singh, SK; Dua, K; Jha, SK |
2021-07-01 | CRISPR-Cas9 gene editing: New hope for Alzheimer's disease therapeutics | Bhardwaj, S; Kesari, KK; Rachamalla, M; Mani, S; Ashraf, GM; Jha, SK; Kumar, P; Ambasta, RK; Dureja, H; Devkota, HP; Gupta, G; Chellappan, DK; Singh, SK; Dua, K; Ruokolainen, J; Kamal, MA; Ojha, S; Jha, NK |
2021-07 | Middle East Respiratory Syndrome (MERS) Virus—Pathophysiological Axis and the Current Treatment Strategies | Alnuqaydan, AM; Almutary, AG; Sukamaran, A; Yang, BTW; Lee, XT; Lim, WX; Ng, YM; Ibrahim, R; Darmarajan, T; Nanjappan, S; Chellian, J; Candasamy, M; Madheswaran, T; Sharma, A; Dureja, H; Prasher, P; Verma, N; Kumar, D; Palaniveloo, K; Bisht, D; Gupta, G; Madan, JR; Singh, SK; Jha, NK; Dua, K; Chellappan, DK |
2021-06-23 | Biosynthetic exosome nanoparticles isolation, characterization, and their diagnostic and therapeutic applications | Anand, K; Chandrasekaran, B; Gupta, G; Dureja, H; Singh, SK; Gulati, M; Chellappan, DK; Balasubramanian, B; Femeela, I; Armugam, VA; Dua, K |
2021-06-08 | Role of chitosan based nanomedicines in the treatment of chronic respiratory diseases. | Gulati, N; Dua, K; Dureja, H |
2021-05 | Current-status and applications of polysaccharides in drug delivery systems | Prasher, P; Sharma, M; Mehta, M; Satija, S; Aljabali, AA; Tambuwala, MM; Anand, K; Sharma, N; Dureja, H; Jha, NK; Gupta, G; Gulati, M; Singh, SK; Chellappan, DK; Paudel, KR; Hansbro, PM; Dua, K |
2021-05 | Oral Nanoemulsion of Fenofibrate: Formulation, Characterization, and In Vitro Drug Release Studies. | Gulati, N; Kumar Chellappan, D; Tambuwala, M; A A Aljabali, A; Prasher, P; Kumar Singh, S; Anand, K; Sharma, A; Kumar Jha, N; Gupta, G; Dua, K; Dureja, H |
2021-04 | Harnessing amphiphilic polymeric micelles for diagnostic and therapeutic applications: Breakthroughs and bottlenecks | Kaur, J; Mishra, V; Singh, SK; Gulati, M; Kapoor, B; Chellappan, DK; Gupta, G; Dureja, H; Anand, K; Dua, K; Khatik, GL; Gowthamarajan, K |
2021-03-09 | Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio‐renal damage in COVID‐19 infection | Singh, Y; Ali, H; Alharbi, KS; Almalki, WH; Kazmi, I; Al‐Abbasi, FA; Anand, K; Dureja, H; Singh, SK; Thangavelu, L; Chellappan, DK; Dua, K; Gupta, G |
2021-02-24 | An overview of vaccine development for COVID-19 | Shahcheraghi, SH; Ayatollahi, J; Aljabali, AA; Shastri, MD; Shukla, SD; Chellappan, DK; Jha, NK; Anand, K; Katari, NK; Mehta, M; Satija, S; Dureja, H; Mishra, V; Almutary, AG; Alnuqaydan, AM; Charbe, N; Prasher, P; Gupta, G; Dua, K; Lotfi, M; Bakshi, HA; Tambuwala, MM |
2021-02-04 | Rutin-loaded liquid crystalline nanoparticles attenuate oxidative stress in bronchial epithelial cells: a PCR validation. | Mehta, M; Paudel, KR; Shukla, SD; Shastri, MD; Satija, S; Singh, SK; Gulati, M; Dureja, H; Zacconi, FC; Hansbro, PM; Chellappan, DK; Dua, K |
2021-02-04 | Activation of TWEAK/Fn14 signaling suppresses TRAFs/NF-κB pathway in the pathogenesis of cancer | Gupta, G; Kazmi, I; Al-Abbasi, FA; Singh, Y; S, R; Rani, S; Mishra, A; Prasher, P; Jha, NK; Thangavelu, L; Dureja, H; Singh, SK; Bhatt, S; Chellappan, DK; Dua, K |